Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
J Toxicol Pathol ; 31(1): 61-64, 2018 Jan.
Article in English | MEDLINE | ID: mdl-29479142

ABSTRACT

Histopathological examination of formalin-fixed paraffin-embedded (FFPE) tissues that had been stored for 30 years was conducted, and reconstructivity of the results was verified. These FFPE tissues, which were from all organs of male and female rats, were re-sectioned and histopathologically examined using hematoxylin and eosin (HE) staining. In particular, the stainability and morphology of HE sections and reproducibility of microscopic findings in the liver and kidney demonstrated in the original final reports were evaluated. Although the stainability of hematoxylin was slightly weaker and some morphological artifacts were observed in tissues in re-prepared slides, these deteriorations in the quality of HE sections were considered to be permissible for histopathological examination so long as control sections were also prepared. Most microscopic findings recorded in the original final reports were confirmed using re-prepared HE sections in the present study. While some focal findings, which were judged to be either incidental or spontaneous in nature, were not observed in the sections as expected, this was not considered to be a problem in reconstructing the results of the original histopathological examination because most findings related to the test articles were generally observed diffusely or multifocally in each organ. We concluded that results of the original histopathological examinations could be reconstructed using paraffin blocks that had been stored for up to 30 years.

2.
Toxicol Pathol ; 45(4): 526-535, 2017 06.
Article in English | MEDLINE | ID: mdl-28641505

ABSTRACT

Pregnant Sprague-Dawley rats were orally administered di( n-butyl)phthalate (DBP; 100 mg/kg/day) on gestation days (GD) 12 to 21. We investigated the male offspring and probed morphological alterations in Sertoli cells at 7, 9, 14, and 17 weeks of age. Parameters assessed in this study included offspring number, sex ratios, body weights, testis weights, seminiferous tubule (ST) profile numbers and diameters, number of vimentin-labeled Sertoli cells, and both testosterone and follicle-stimulating hormone (FSH) levels. Testicular weight/body weight ratios and the numbers and diameters of ST in maximum transverse testicular sections were statistically similar at weeks 7 and 9; however, at weeks 14 and 17, they were statistically different and displayed higher BrdU-positive Sertoli cells/Sertoli cell ratios in the DBP treatment group. Noteworthily, the serum FSH levels were higher and testicular testosterone levels were lower in the DBP treatment group. To our knowledge, the present study is the first to report that in utero DBP exposure significantly increased Sertoli cell numbers and their cellular proliferation from postpuberty to adulthood, with a significant decrease in testicular testosterone and an increase in FSH.


Subject(s)
Dibutyl Phthalate/administration & dosage , Dibutyl Phthalate/toxicity , Maternal Exposure/adverse effects , Prenatal Exposure Delayed Effects/physiopathology , Sexual Maturation/drug effects , Animals , Animals, Newborn , Female , Follicle Stimulating Hormone/blood , Male , Organ Size/drug effects , Pregnancy , Rats , Rats, Sprague-Dawley , Seminiferous Tubules/drug effects , Seminiferous Tubules/metabolism , Sertoli Cells/drug effects , Sertoli Cells/metabolism , Testis/drug effects , Testis/metabolism , Testosterone/blood
3.
Microscopy (Oxf) ; 66(3): 198-203, 2017 Jun 01.
Article in English | MEDLINE | ID: mdl-28339760

ABSTRACT

Angiogenesis is essential for tumor growth, and an enhanced vasculature supplying nutrients and oxygen might reflect malignant potential. L-type amino acid transporter 1 (LAT1/4F2hc) comprises a major nutrient transport system responsible for the Na+-independent transport of large neutral amino acids. Seventy five to seventy eight percent N-butyl-N-(4-hydroxybutyl) nitrosamine-induced rat bladder carcinoma cells showed high LAT1/4F2hc expression. While the intracarcinoma microvasculatures of fenestrated endothelial cells highly expressing LAT1/4F2hc might progressively transport essential amino acids from the microvasculatures to the extracellular matrix, non-fenestrated endothelial cells and pericytes did not. The present study revealed that the tumor angiogenesis is one of target anti-L-type amino acid transporter 1 drug.


Subject(s)
Butylhydroxybutylnitrosamine/adverse effects , Fusion Regulatory Protein 1, Heavy Chain/ultrastructure , Large Neutral Amino Acid-Transporter 1/chemistry , Microvessels/ultrastructure , Urinary Bladder Neoplasms/blood supply , Urinary Bladder Neoplasms/ultrastructure , Animals , Immunohistochemistry/methods , Large Neutral Amino Acid-Transporter 1/ultrastructure , Male , Microscopy, Electron , Rats , Rats, Wistar , Urinary Bladder Neoplasms/chemically induced
4.
Exp Toxicol Pathol ; 65(4): 457-62, 2013 May.
Article in English | MEDLINE | ID: mdl-22402172

ABSTRACT

Abnormality in hematological condition including hemolytic disorders has been suggested one of the risk factor of pulmonary thrombosis. We previously reported that phenylhydrazine (PHZ) could induce acute thrombosis in the rat lung. In this study, time-related hematological and histopathological changes were evaluated in PHZ-treated rats to reveal the pathogenesis of pulmonary thrombosis in hemolytic condition. Male Sprague-Dawley rats were administered PHZ at 40 mg/kg/day daily for up to 4 days (n=6). At 24 h after the last administration (i.e. on days 1, 2, 3, or 4), animals were euthanized and samples were subjected to hematology, light microscopy, and electron microscopy. PHZ-treated rats developed severe anemia on day 1 or later. On day 2 and after, congestion in the alveolar septa corresponding to accumulation of deformed/ghost erythrocytes in the alveolar capillaries was observed, which was the earliest change that preceded thrombus formation. Focal fibrin deposition in the alveolar septa was noted on day 3 and it expanded widely by day 4, while endothelial injury were minimally noted just on day 4. These congestive/thrombotic changes were predominant in the pulmonary capillaries. Changes in hemostatic parameters were noted only on day 4; which were prolonged prothrombin time and activated partial thromboplastin time, greatly increased plasma thrombin-antithrombin complex levels with statistical significance, and slightly decreased fibrinogen levels. In conclusion, the trigger of acute pulmonary thrombosis in PHZ-treated rats was considered to be regional stasis resulting from blockage caused by the deformed erythrocytes, and subsequent systemic hemostatic disruption.


Subject(s)
Lung/pathology , Pulmonary Embolism/pathology , Thrombosis/pathology , Animals , Disease Models, Animal , Lung/drug effects , Male , Microscopy, Electron, Transmission , Oxidants/toxicity , Phenylhydrazines/toxicity , Pulmonary Embolism/chemically induced , Rats , Rats, Sprague-Dawley , Thrombosis/chemically induced
5.
Exp Toxicol Pathol ; 64(4): 333-8, 2012 May.
Article in English | MEDLINE | ID: mdl-20965707

ABSTRACT

SHR/NDmcr-cp (SHR/NDcp) rats, which carry a nonsense mutation of the leptin receptor gene, are known to spontaneously develop hypertension, obesity and hyperlipidemia, and have therefore found use as an animal model of the metabolic syndrome and type 2 diabetes. However, some recent studies on SHR/NDcp rats revealed only mild elevation of blood glucose levels. To investigate whether metabolic factors including blood glucose and histopathological alterations of SHR/NDcp rats deteriorate with a diabetogenic diet, biochemical and histopathological examinations were conducted with animals fed normal or diabetogenic diets for 20 weeks. SHR/NDcp rats receiving the normal diet displayed obesity, hypertension, hyperlipidemia, and mild elevation of blood glucose and HbA1c levels. Urinary glucose excretion was noted in only 1 out of 6 animals. Histologically, macro- and micro-vesicular steatosis in the liver, glomerular and tubular damages in the kidney and islet hyperplasia mainly of beta cells in the pancreas were characteristically noted. In SHR/NDcp rats fed the diabetogenic diet, obesity was more severe, with higher blood glucose and HbA1c levels, increased numbers of animals with urinary glucose excretion, and more pronounced hepatic steatosis and renal tubular changes. However, elevation of blood glucose levels and urinary glucose excretion proved transient. These observations indicate that the diabetic state and associated histopathological alterations in SHR/NDcp rats are exacerbated by feeding a diabetogenic diet, but the effects are limited. Elevated islet function with compensative insulin secretion might be related to amelioration of the hyperglycemic state. Further diet modification could be needed to induce a more prominent and persistent diabetic state in SHR/NDcp rats.


Subject(s)
Diet , Hyperglycemia/diet therapy , Hyperlipidemias/diet therapy , Hypertension/diet therapy , Metabolic Syndrome/diet therapy , Obesity/diet therapy , Animals , Blood Glucose , Blood Pressure/physiology , Body Weight/physiology , Disease Models, Animal , Fatty Liver/metabolism , Fatty Liver/pathology , Glycated Hemoglobin/analysis , Glycosuria , Hyperglycemia/metabolism , Hyperglycemia/pathology , Hyperlipidemias/metabolism , Hyperlipidemias/pathology , Hyperplasia/metabolism , Hyperplasia/pathology , Hypertension/metabolism , Hypertension/pathology , Islets of Langerhans/metabolism , Islets of Langerhans/pathology , Kidney/metabolism , Kidney/pathology , Male , Metabolic Syndrome/metabolism , Metabolic Syndrome/pathology , Obesity/metabolism , Obesity/pathology , Rats , Rats, Inbred SHR , Rats, Inbred WKY
6.
J Toxicol Pathol ; 23(1): 59-62, 2010 Mar.
Article in English | MEDLINE | ID: mdl-22319226

ABSTRACT

A hepatic nodule was noted in a C57BL/6J mouse with diet-induced obesity at 53 weeks of age. Macroscopically, a protruding yellowish white nodule was observed on the visceral surface of the left lateral lobe. Light microscopy demonstrated clear demarcation from the compressed adjacent parenchyma, with loss of the distinct lobular pattern. The proliferating cells of the lesion varied in shape and showed cellular atypia and prominent nucleoli along with vacuoles of various sizes. Some of the cells contained various-sized eosinophilic inclusion bodies in their cytoplasm, and electron microscopy revealed the presence of lipid droplets in the rough endoplasmic reticulum. Eosinophilic inclusions were observed as electron dense granular material in the rough endoplasmic reticulum, with one or a few low density central cores. A diagnosis of hepatocellular adenoma was made based on these findings.

8.
J Toxicol Sci ; 32(2): 161-77, 2007 May.
Article in English | MEDLINE | ID: mdl-17538240

ABSTRACT

In the present study, we investigated the potential toxic effects of 2-week oral treatment with T-0126, a novel microsomal triglyceride transfer protein (MTP) inhibitor, on the liver and intestine in male and female rats. Administration of T-0126 decreased serum lipids and resulted in fat accumulation in the liver and the small intestine. In addition, slight changes in the liver, including an increase in serum aminotransferase (AST and ALT) activity, presence of focal inflammatory lesions, and prolongation of PT and APTT were observed after treatment with T-0126. These changes may be related to a mechanism based on malabsorption of fat, fat-soluble antioxidants, and vitamin K, although we cannot exclude other potential mechanisms such as direct cytotoxicity of T-0126.


Subject(s)
Benzamides/toxicity , Carrier Proteins/antagonists & inhibitors , Indoles/toxicity , Intestine, Small/drug effects , Liver/drug effects , Microsomes/drug effects , Administration, Oral , Animals , Carrier Proteins/metabolism , Chemistry, Clinical , Dose-Response Relationship, Drug , Female , Hematologic Tests , Hepatocytes/drug effects , Hepatocytes/ultrastructure , Intestine, Small/metabolism , Intestine, Small/pathology , Lipids/blood , Liver/metabolism , Liver/pathology , Lymph Nodes/drug effects , Lymph Nodes/metabolism , Lymph Nodes/pathology , Male , Organ Size/drug effects , Rats , Rats, Inbred Strains
9.
Exp Toxicol Pathol ; 56(4-5): 235-44, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15816352

ABSTRACT

Streptozotocin (SZ) is known to exert toxic effects not only on pancreatic islet beta cells but also on other organs including liver. For analyzing changes in genes expression associated with SZ toxicity, we performed DNA microarray analyses on the liver obtained from SZ-treated mice. Eight-week-old male ICR mice were treated i.p. with 200 mg/kg of SZ, and the blood and liver were taken at 6, 24 and 48 h after the treatment. Labeled cRNA prepared from total RNA of the liver was hybridized to the GeneChip Murine Genome U74A V.2 (Affymetrix). The number of the probe sets, which were clearly up-regulated or down-regulated, were over 100 at 6 and 24h after the SZ-treatment, and it decreased at 48 h after the treatment. Many of the up-regulated genes were categorized into cell cycle/apoptosis related genes, immune/allergy related genes and stress response/xenobiotic metabolism related genes. On the other hand, genes related to glucose, lipid and protein metabolisms were down-regulated. These changes started prior to the elevation of the serum glucose levels, indicating the direct action of SZ on the liver rather than the secondary effect of diabetes. This may be related with the previously reported hepatic changes such as lipid peroxidation, mitochondrial swelling and inhibition of hepatocyte proliferation observed before the development of hyperglycemia.


Subject(s)
Antibiotics, Antineoplastic/toxicity , Gene Expression Profiling , Liver/physiology , Oligonucleotide Array Sequence Analysis , Streptozocin/toxicity , Animals , Apoptosis/drug effects , Apoptosis/physiology , Liver/drug effects , Male , Mice , Mice, Inbred ICR , Models, Biological , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction/genetics
10.
Exp Toxicol Pathol ; 56(4-5): 245-53, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15816353

ABSTRACT

Streptozotocin (SZ) is known to exert toxic effects not only on pancreatic islet beta cells but also on other organs including the liver. For analyzing direct effects of SZ on hepatocytes, we performed morphological analysis and DNA microarray analysis on mouse primary cultured hepatocytes. Hepatocytes were taken from non-treated Crj:CD-1(ICR) mice. The primary cultured hepatocytes were treated with SZ at concentrations of 0, 1, 3, 10, 30 and 100 mM. After the treatment for about 6 or 24h, cell survival assay using tetrazolium salt (WST-1), light microscopic/electron microscopic analysis and gene expression analysis were performed. For the gene expression analysis, target (labeled cRNA) prepared from total RNA of the hepatocytes was hybridized to the GeneChip Murine Genome U74A V.2 (Affymetrix). The signal intensity calculation and scaling were performed using Microarray Suite Software Ver 5.0. IC50 of the cell survival assay was around 62 mM at 6 h exposure and 7 mM at 24 h exposure. Marked chromatin margination was observed in nuclei of the hepatocytes treated with SZ at concentrations of 3 or 10mM. Gene expression analysis revealed similar expression changes to those of in vivo, i.e. up-regulation in cell proliferation/ apoptosis related genes, and down-regulation of lipid metabolism related genes. These results potently supported the hypothesis that many of the hepatic alteration including histopathological and gene expression changes are induced by direct effect of SZ rather than by the secondary effect of the hyperglycemia or hypoinsulinemia.


Subject(s)
Antibiotics, Antineoplastic/toxicity , Hepatocytes/drug effects , Hepatocytes/pathology , Streptozocin/toxicity , Animals , Apoptosis/drug effects , Cell Survival/drug effects , Cells, Cultured , Gene Expression/drug effects , Gene Expression Profiling , Hepatocytes/ultrastructure , Male , Mice , Microscopy, Electron, Transmission , Oligonucleotide Array Sequence Analysis
11.
Exp Toxicol Pathol ; 55(6): 467-80, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15384252

ABSTRACT

We have reported the streptozotocin (SZ)-induced hepatic lesions in the subacute phase (4 to 12 weeks after the treatment), which are characterized by appearance of oncocytic hepatocytes, cytomegalic hepatocytes and bile duct hyperplasia. In this study, we focused on the acute phase (6 to 48 hours after the treatment) of the SZ-induced hepatic lesions of mice to clarify the onset of the hepatic alterations, especially before the induction of hyperglycemia. Livers were taken from 8-week-old Crj:CD-1 (ICR) male mice at 6, 12, 24, 36 and 48 hours after the 200 mg/kg b.w. of SZ-injection. SZ-induced hyperglycemia was noted at 36 and 48 hours after the treatment, but the hepatic changes including lipid peroxidation, mitochondrial swelling, peroxisome proliferation and inhibition of hepatocyte proliferation occurred before the elevation of the serum glucose levels. The present findings indicate the direct effects of SZ on hepatocytes rather than the secondary effects of diabetes, and certain correlations between the hepatocytic changes in the acute phase and those in the subacute one. In addition, ulcer and submucosal edema of the gallbladder were observed at 36 or 48 hours after the SZ-treatment, which can be a novel finding in SZ-treated animal.


Subject(s)
Diabetes Mellitus, Experimental/pathology , Liver Diseases/pathology , Liver/drug effects , Streptozocin/toxicity , Acute Disease , Animals , Blood Glucose/analysis , Chemical and Drug Induced Liver Injury , Diabetes Mellitus, Experimental/blood , Diabetes Mellitus, Experimental/complications , Gallbladder/drug effects , Gallbladder/pathology , Gallbladder Diseases/chemically induced , Gallbladder Diseases/complications , Gallbladder Diseases/pathology , Hepatocytes/drug effects , Hepatocytes/ultrastructure , Hyperglycemia/chemically induced , Insulin/blood , Liver/pathology , Liver Diseases/complications , Male , Mice , Mice, Inbred ICR , Mitochondria, Liver/drug effects , Mitochondria, Liver/ultrastructure , Mitochondrial Swelling/drug effects , Organ Size/drug effects , Time Factors , Ulcer/chemically induced , Ulcer/complications , Ulcer/pathology
12.
Exp Toxicol Pathol ; 53(6): 447-52, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11926286

ABSTRACT

6-Sulfanilamidoindazole (6SAI) induces selflimiting arthritis in rats. Since close relationships exist between arthritis and endotoxin, four experiments were conducted to clarify the relationship between endotoxin and 6SAI-induced arthritis. Endotoxin levels in the plasma from the abdominal aorta and portal vein from rats that had 6SAI (500 mg/kg) administered orally for up to 7 days remained within the control values at day 1 and day 3, and were significantly elevated at day 7. Endotoxin levels in the synovial fluid from the same rats showed no significant change. Ankle swelling and redness in rats treated 11 consecutive days with 6SAI did not ameliorate when coadministered with an anti-endotoxin agent, polymyxin B sulfate. Histopathological examination on the ankles of rats treated orally with non-arthiritogenic sulfonamides including sulfonamide, sulfamethoxazole and sulfadimethoxin (250 and 500 mg/kg/day, each compound) for 2 weeks demonstrated no inflammatory changes, while hyperplasia/hypertrophy of thyroid epithelial cells were frequently observed. When histopathological changes in the ankles from rats coadministered with 6SAI and lipopolysaccharide (LPS, Escherihia coli O55:B5, 50 microg/kg, i.v.) were compared with those in rats treated with 6SAI or LPS alone, the ankles from the 6SAI+LPS treated animals had marked edematous inflammation in the synovium and surrounding connective tissues, whereas the LPS-group had only mild focal infiltration of polymorphonuclear leukocytes in the synovium and the 6SAI-group showed no apparent changes. These results suggest that endotoxin is not a direct cause but a possible acceralating factor of 6SAI-induced arthritis, and that the effects of 6SAI on gut bacteria is not related with the pathogenesis of this model.


Subject(s)
Arthritis, Experimental/blood , Endotoxins/blood , Administration, Oral , Animals , Arthritis, Experimental/chemically induced , Arthritis, Experimental/pathology , Disease Models, Animal , Drug Antagonism , Escherichia coli , Lipopolysaccharides/administration & dosage , Lipopolysaccharides/pharmacology , Male , Polymyxin B/pharmacology , Rats , Rats, Inbred Strains , Serositis/blood , Serositis/chemically induced , Serositis/parasitology , Sulfanilamides/toxicity , Synovial Fluid/drug effects , Synovial Fluid/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...